Ingo Hartlapp

Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo

Ingo Hartlapp, Riichiro Abe, Tina Peng et al. · The FASEB Journal · 2001 · 262 citations

Life Sciences, Bioengineering, Cell Biology +13

Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial

Volker Kunzmann, Jens T. Siveke, Hana Algül et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 197 citations

Medicine, Oncology, Pharmacology +10

A recombinant bispecific single‐chain antibody induces targeted, supra‐agonistic CD28‐stimulation and tumor cell killing

Ludger Große‐Hovest, Ingo Hartlapp, Wolfgang Marwan et al. · European Journal of Immunology · 2003 · 62 citations · Full text

Medicine, Immunology, Oncology +17

Conversion rate in locally advanced pancreatic cancer (LAPC) after nab-paclitaxel/gemcitabine- or FOLFIRINOX-based induction chemotherapy (NEOLAP): Final results of a multicenter randomised phase II AIO trial

Volker Kunzmann, Hana Algül, Eray Goekkurt et al. · Annals of Oncology · 2019 · 39 citations · Full text

Medicine, Oncology, Pharmacology +7

Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)

Ingo Hartlapp, D. Valta-Seufzer, Jens T. Siveke et al. · ESMO Open · 2022 · 36 citations · Full text

Medicine, Oncology, Chemotherapy +8